• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视无机纳米颗粒作为有前途的治疗剂:肿瘤治疗学中的范式转变。

Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics.

机构信息

Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, 202002, India.

Interdisciplinary Nanotechnology Centre, Aligarh Muslim University, Aligarh, 202002, India.

出版信息

Eur J Pharm Sci. 2021 Sep 1;164:105892. doi: 10.1016/j.ejps.2021.105892. Epub 2021 May 27.

DOI:10.1016/j.ejps.2021.105892
PMID:34052295
Abstract

Cancer remains a global health problem largely due to a lack of effective therapies. Major cancer management strategies include chemotherapy, surgical resection, and radiation. Unfortunately, these strategies have a number of limitations, such as non-specific side effects, uneven delivery of the drugs, and lack of proper monitoring technology. Inorganic nanoparticles (NPs) are considered promising agents in treating and tracing cancer due to their unique physicochemical properties such as the controlled release of drugs, bioavailability, biocompatibility, stability, and large surface area. Also, they enhance the solubility of hydrophobic drugs, prolong their circulation time, prevent undesired off-targeting and subsequent side effects, making them efficient particles in cancer theranostics. Promising inorganic-NPs include gold, selenium, silica, and oxide NPs. Further, several techniques are used to modify the surface of inorganic-NPs, making them more efficient for the effective transport of therapeutic cargos to overcome cellular barriers. Thus, inorganic-NPs function effectively, surmounting the intrinsic drawbacks of traditional organic NPs. This mini-review summarizes the significant inorganic-NPs, their properties, surface modifications, cellular uptake, and bio-distributions, along with their potential use in cancer theranostics. We also discuss the promises and challenges faced during the inorganic-NPs mediated therapeutic approach for cancer and these particles' status in the clinical setting.

摘要

癌症仍然是一个全球性的健康问题,主要是由于缺乏有效的治疗方法。主要的癌症管理策略包括化疗、手术切除和放疗。不幸的是,这些策略有许多局限性,如非特异性副作用、药物分布不均以及缺乏适当的监测技术。

由于具有独特的物理化学性质,如药物的控制释放、生物利用度、生物相容性、稳定性和大的表面积,无机纳米粒子(NPs)被认为是治疗和追踪癌症的有前途的药物。此外,它们还提高了疏水性药物的溶解度,延长了它们的循环时间,防止了不必要的脱靶和随后的副作用,使它们成为癌症治疗学中有效的粒子。有前途的无机-NPs 包括金、硒、硅和氧化物 NPs。

此外,还使用了几种技术来修饰无机-NPs 的表面,使它们更有效地将治疗性 cargo 有效输送到细胞中,以克服细胞屏障。因此,无机-NPs 能够有效地发挥作用,克服了传统有机 NPs 的固有缺陷。

本综述总结了重要的无机-NPs,及其性质、表面修饰、细胞摄取和生物分布,以及它们在癌症治疗学中的潜在用途。我们还讨论了在无机-NPs 介导的癌症治疗方法中面临的挑战和这些颗粒在临床环境中的地位。

相似文献

1
Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics.重新审视无机纳米颗粒作为有前途的治疗剂:肿瘤治疗学中的范式转变。
Eur J Pharm Sci. 2021 Sep 1;164:105892. doi: 10.1016/j.ejps.2021.105892. Epub 2021 May 27.
2
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.无机纳米粒子在癌症治疗中的应用:从实验室到临床的转变。
Curr Med Chem. 2018;25(34):4269-4303. doi: 10.2174/0929867325666171229141156.
3
Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.基于无机纳米粒子的药物递送至靶向乳腺癌治疗学的新进展。
Adv Colloid Interface Sci. 2024 Jul;329:103204. doi: 10.1016/j.cis.2024.103204. Epub 2024 May 22.
4
Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.杂化蛋白-无机纳米颗粒:从肿瘤靶向药物递送到癌症成像。
J Control Release. 2016 Dec 10;243:303-322. doi: 10.1016/j.jconrel.2016.10.023. Epub 2016 Oct 26.
5
Surface Engineering of Nanoparticles toward Cancer Theranostics.纳米颗粒的表面工程用于癌症治疗与诊断。
Acc Chem Res. 2023 Jul 4;56(13):1766-1779. doi: 10.1021/acs.accounts.3c00122. Epub 2023 Jun 14.
6
Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.多功能纳米粒子在精准癌症治疗中的应用:纳米载体设计与功能化的考虑因素。
Curr Top Med Chem. 2020;20(27):2427-2441. doi: 10.2174/1568026620666200825170030.
7
In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.化学设计的介孔硅纳米粒子的体内生物安全性评估和诊断/治疗应用。
Adv Mater. 2013 Jun 18;25(23):3144-76. doi: 10.1002/adma.201205292. Epub 2013 May 17.
8
Overcoming the stability, toxicity, and biodegradation challenges of tumor stimuli-responsive inorganic nanoparticles for delivery of cancer therapeutics.克服肿瘤刺激响应性无机纳米粒子在输送癌症治疗药物方面的稳定性、毒性和生物降解性挑战。
Expert Opin Drug Deliv. 2019 Oct;16(10):1095-1112. doi: 10.1080/17425247.2019.1662786. Epub 2019 Sep 3.
9
Applications of Metallic Nanoparticles in the Skin Cancer Treatment.金属纳米粒子在皮肤癌治疗中的应用。
Biomed Res Int. 2022 Nov 14;2022:2346941. doi: 10.1155/2022/2346941. eCollection 2022.
10
Surface engineering of inorganic nanoparticles for imaging and therapy.无机纳米粒子的表面工程用于成像和治疗。
Adv Drug Deliv Rev. 2013 May;65(5):622-48. doi: 10.1016/j.addr.2012.08.015. Epub 2012 Sep 6.

引用本文的文献

1
Nucleus delivery of doxorubicin by gadolinium-functionalized carbon dot drug delivery system for HCC imaging and therapy.钆功能化碳点药物递送系统用于肝癌成像和治疗的阿霉素细胞核递送
Mikrochim Acta. 2025 Aug 23;192(9):616. doi: 10.1007/s00604-025-07474-6.
2
Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies.肿瘤免疫治疗中 IDO1 抑制剂的纳米递药优化:挑战与策略。
Int J Nanomedicine. 2024 Aug 28;19:8847-8882. doi: 10.2147/IJN.S458086. eCollection 2024.
3
Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications.
隐形纳米载体在癌症治疗中的应用:设计、功能及临床应用的综合综述。
AAPS PharmSciTech. 2024 Jun 18;25(6):140. doi: 10.1208/s12249-024-02843-5.
4
Recent Advancements and Unexplored Biomedical Applications of Green Synthesized Ag and Au Nanoparticles: A Review.绿色合成的 Ag 和 Au 纳米粒子的最新进展和未探索的生物医学应用:综述。
Int J Nanomedicine. 2024 Apr 3;19:3187-3215. doi: 10.2147/IJN.S453775. eCollection 2024.
5
Nanocarriers for delivery of siRNA as gene silencing mediator.用于递送作为基因沉默介质的小干扰RNA的纳米载体。
EXCLI J. 2022 Aug 1;21:1028-1052. doi: 10.17179/excli2022-4975. eCollection 2022.
6
siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review.基于 siRNA 的纳米治疗学作为免疫介导性疾病的新兴治疗模式:初步综述。
Cell Biol Int. 2022 Sep;46(9):1320-1344. doi: 10.1002/cbin.11841. Epub 2022 Jul 13.
7
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.针对侵袭性神经胶质瘤肿瘤微环境的纳米治疗。
Adv Drug Deliv Rev. 2022 Sep;188:114415. doi: 10.1016/j.addr.2022.114415. Epub 2022 Jul 3.
8
CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells.CD133 功能化金纳米粒子作为携带他拉唑帕尼(CB-839)对抗肿瘤干细胞的载体平台。
Int J Mol Sci. 2022 May 13;23(10):5479. doi: 10.3390/ijms23105479.
9
Inorganic Nanoparticles in Bone Healing Applications.骨愈合应用中的无机纳米颗粒
Pharmaceutics. 2022 Mar 31;14(4):770. doi: 10.3390/pharmaceutics14040770.
10
Functional Polyion Complex Micelles for Potential Targeted Hydrophobic Drug Delivery.功能化聚离子复合物胶束用于潜在的靶向疏水性药物传递。
Molecules. 2022 Mar 28;27(7):2178. doi: 10.3390/molecules27072178.